A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

• Status: Completed
• Trial end date: 2007-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Collaborator: Sanofi
• Treatments: Insulin; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diabetes mellitus Type 2

• Failing two or more oral anti-diabetic agents

Exclusion Criteria:

• Asthma, COPD

• Smoking